| Patent | Date |
|---|
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma
App 20210317532 - Vogelstein; Bert ; et al. | 2021-10-14 |
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
Grant 10,894,987 - Vogelstein , et al. January 19, 2 | 2021-01-19 |
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
Grant 10,837,064 - Vogelstein , et al. November 17, 2 | 2020-11-17 |
Anti-human TIM-3 antibodies and methods of use thereof
Grant 10,752,688 - Yang , et al. A | 2020-08-25 |
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
Grant 10,704,108 - Vogelstein , et al. | 2020-07-07 |
Modified Antigen-binding Fab Fragments And Antigen-binding Molecules Comprising The Same
App 20190309092 - HU; Chih-Yung ; et al. | 2019-10-10 |
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma
App 20190106752 - Vogelstein; Bert ; et al. | 2019-04-11 |
Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules
App 20180362659 - Bigner; Darell D. ; et al. | 2018-12-20 |
Anti-VEGFR antibody and uses thereof
Grant 10,138,300 - Lai , et al. Nov | 2018-11-27 |
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma
App 20180282821 - Vogelstein; Bert ; et al. | 2018-10-04 |
Dual specific immunotoxin for brain tumor therapy
Grant 10,072,084 - Bigner , et al. September 11, 2 | 2018-09-11 |
Methods for using antibodies for 3' iso-LM1 and 3', 6'-iso-LD1tumor gangliosides
Grant 10,052,382 - Bigner , et al. August 21, 2 | 2018-08-21 |
Human bispecific EGFRvIII and CD3 antibody engaging molecules
Grant 10,053,514 - Bigner , et al. August 21, 2 | 2018-08-21 |
Anti-vegfr Antibody And Uses Thereof
App 20180186884 - LAI; JIANN-SHIUN ; et al. | 2018-07-05 |
Anti-human Tim-3 Antibodies And Methods Of Use Thereof
App 20180186881 - Yang; Yu-Chen ; et al. | 2018-07-05 |
Anti-vegfr Antibody And Uses Thereof
App 20170233480 - LAI; JIANN-SHIUN ; et al. | 2017-08-17 |
Human bispecific EGFRvIII antibody and CD3 engaging molecules
Grant 9,676,858 - Bigner , et al. June 13, 2 | 2017-06-13 |
Genetic Alterations in Isocitrate Dehydrogenase and Other Genes in Malignant Glioma
App 20170081730 - Vogelstein; Bert ; et al. | 2017-03-23 |
Dual Specific Immunotoxin for Brain Tumor Therapy
App 20170051064 - Bigner; Darell D. ; et al. | 2017-02-23 |
Dual specific immunotoxin for brain tumor therapy
Grant 9,492,564 - Bigner , et al. November 15, 2 | 2016-11-15 |
Antibodies for Tumor Gangliosides
App 20160272730 - Bigner; Darell ; et al. | 2016-09-22 |
Antibody for 3'-isoLM1 and 3',6'-iso-LD1 gangliosides
Grant 9,441,048 - Bigner , et al. September 13, 2 | 2016-09-13 |
Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules
App 20160168263 - Bigner; Darell D. ; et al. | 2016-06-16 |
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
Grant 9,353,418 - Vogelstein , et al. May 31, 2 | 2016-05-31 |
Bispecific EGFRvIII x CD3 antibody engaging molecules
Grant 9,249,217 - Bigner , et al. February 2, 2 | 2016-02-02 |
Anti-Podoplanin Antibodies and Methods of Use
App 20150368353 - BIGNER; Darell ; et al. | 2015-12-24 |
Antibodies and immunotoxins that target human glycoprotein NMB
Grant 9,115,196 - Kuan , et al. August 25, 2 | 2015-08-25 |
HUMAN BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES
App 20150132306 - Bigner; Darell ; et al. | 2015-05-14 |
Dual Specific Immunotoxin for Brain Tumor Therapy
App 20140322248 - BIGNER; Darell ; et al. | 2014-10-30 |
Anti-MRP3 antibodies and methods of use
Grant 8,835,608 - Kuan , et al. September 16, 2 | 2014-09-16 |
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma
App 20140187764 - VOGELSTEIN; Bert ; et al. | 2014-07-03 |
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
Grant 8,685,660 - Vogelstein , et al. April 1, 2 | 2014-04-01 |
Anti-podoplanin Antibodies And Methods Of Use
App 20140017266 - Bigner; Darell ; et al. | 2014-01-16 |
Antibodies For Tumor Gangliosides
App 20140010829 - Bigner; Darell ; et al. | 2014-01-09 |
Antibodies and Immunotoxins that Target Human Glycoprotein NMB
App 20130245244 - KUAN; Chien-Tsun ; et al. | 2013-09-19 |
Antibodies and immunotoxins that target human glycoprotein NMB
Grant 8,445,216 - Kuan , et al. May 21, 2 | 2013-05-21 |
Dual Specific Immunotoxin for Brain Tumor Therapy
App 20130022598 - Bigner; Darell ; et al. | 2013-01-24 |
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma
App 20120202207 - VOGELSTEIN; Bert ; et al. | 2012-08-09 |
BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES
App 20120189630 - BIGNER; Darell D. ; et al. | 2012-07-26 |
Antibodies And Immunotoxins That Target Human Glycoprotein Nmb
App 20120122121 - KUAN; Chien-Tsun ; et al. | 2012-05-17 |
Antibodies and immunotoxins that target human glycoprotein NMB
Grant 8,039,593 - Kuan , et al. October 18, 2 | 2011-10-18 |
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma
App 20110229479 - Vogelstein; Bert ; et al. | 2011-09-22 |
Anti-mrp3 Antibodies And Methods Of Use
App 20100290984 - Kuan; Chien-Tsun ; et al. | 2010-11-18 |
Anti-Tumor Antibodies
App 20100047164 - Bigner; Darell ; et al. | 2010-02-25 |
Dual Specific Immunotoxin for Brain Tumor Therapy
App 20090269343 - Bigner; Darell ; et al. | 2009-10-29 |
Antibodies And Immunotoxins That Target Human Glycoprotein Nmb
App 20090252750 - Kuan; Chien-Tsun ; et al. | 2009-10-08 |
Anti-tenascin Monoclonal Antibody Immunoassays And Diagnostic Kits
App 20080145875 - Bigner; Darell D. ; et al. | 2008-06-19 |
Anti-tenascin monoclonal antibody immunoassays and diagnostic kits
App 20060115862 - Bigner; Darell D. ; et al. | 2006-06-01 |
Nucleic acids encoding immunotoxins containing a disulfide-stabilized antibody fragment replacing half or more of domain IB of pseudomonas exotoxin, and methods of use of the encoded immunotoxins
Grant 6,074,644 - Pastan , et al. June 13, 2 | 2000-06-13 |
Immunotoxin containing a disulfide-stabilized antibody fragment joined to a Pseudomonas exotoxin that does not require proteolytic activation
Grant 5,980,895 - Pastan , et al. November 9, 1 | 1999-11-09 |
| 